Advertisement

Topics

Boston Biomedica Incorporated Company Profile

22:53 EST 23rd November 2017 | BioPortfolio

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral Hepatitis.

Location

375 West Street
West Bridgewater
MA
02379
United States of America

Contact

Phone: 508 580 1900
Fax: 508 580 1110


News Articles [411 Associated News Articles listed on BioPortfolio]

Oxford BioMedica could pocket $100m on Novartis CAR-T cell success

Oxford BioMedica saw its share price jump 21% after the US FDA approved Kymriah, the gene modified cell therapy made with the firm’s lentiviral vectors.

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Oxford BioMedica inks $100 million supply agreement

Oxford BioMedica has signed an agreement for the commercial and clinical supply of lentiviral vectors…

Oxford BioMedica (OXB) - Kymriah approved - royalties to OXB assured

Edison Investment Research - Pharmaceutical & healthcare - Oxford BioMedica: Kymriah (tisagenlecleucel/CTL019), for which Oxford BioMedica (OXB) provides the key lentiviral vector component, has been ...

Oxford BioMedica secures commercial supply licence from UK MHRA

Oxford BioMedica has been granted a Manufacturer/Importer License (MIA) from the UK Medicines and Healthcare products Regulatory Agency (MHRA), to manufacture and distribute lentiviral vector material...

Oxford BioMedica signs $100m CAR-T deal with Novartis

Oxford BioMedica has signed a deal worth up to $100m with Novartis to supply modified viruses used to generate its CAR-T therapies. The deal represents a major financial boost for the UK biotech fir...

Oxford BioMedica could get $100m following CAR-T approval

UK biotech Oxford BioMedica could earn more than $100 million from Novartis for providing a key component in the recently approved CAR-T cancer cell therapy. The FDA this week approved Novartis’ c...

Oxford BioMedica wins big contract for Novartis cell therapy

LONDON (Reuters) - Novartis has signed a major contract with Oxford BioMedica that could earn the British company more than $100 million over three years for supplying the Swiss drugmaker with materia...

PubMed Articles [152 Associated PubMed Articles listed on BioPortfolio]

The Boston Marathon versus the World Marathon Majors.

To compare finish times across WMM races for Boston, London, Berlin, Chicago and New York Marathons.

Vision retention in early versus delayed glaucoma surgical intervention in patients with Boston Keratoprosthesis type 1.

The loss of vision following Boston Keratoprosthesis (BKPro) surgery due to glaucoma occurs at a high frequency as diagnosis and management of glaucoma after this procedure pose challenges.

Measuring Forward Light Scatter by the Boston Keratoprosthesis in Various Configurations.

Light scatter results in degradation of visual function. An optical bench model was used to identify the origins of scatter in the setting of a Boston keratoprosthesis (KPro). The effect of various mo...

Reliability and Validation of the Greek Version of the Boston Carpal Tunnel Questionnaire.

The Boston Carpal Tunnel Questionnaire (BCTQ) is an easy, brief, self-administered questionnaire developed by Levine et al for the assessment of severity of symptoms and functional status of patients ...

The willingness of people who inject drugs in Boston to use a supervised injection facility.

In Massachusetts, the number of opioid-related deaths has increased 350% since 2000. In the setting of increasing overdose deaths, one potential intervention is Supervised Injection Facilities (SIFs)....

Clinical Trials [144 Associated Clinical Trials listed on BioPortfolio]

The Boston Scientific ENOVUS Trial

A prospective, actively controlled, consecutively enrolling, non-randomized multi center clinical evaluation of the safety and efficacy of the Boston Scientific ENOVUS AAA Endograft when u...

Boston Scientific COMET Wire Validation Study

Summary of Study Aims To assess, in a randomised fashion: 1. performance of Boston Scientific Pressure Wire versus St Jude Pressure Wire 2. performance of Boston Scientific Pr...

The Boston Scientific ACCESS Trial

The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialys...

EXCEL: Change in Cardiometabolic Disease Risk Factors During an Interactive Fitness Program

Childhood obesity has increased in prevalence over the past several decades and is predictive of adult type 2 diabetes and cardiovascular disease (CVD). Recent studies of children and yout...

Stenting of the Superficial Femoral and/or Proximal Popliteal Artery Project

To determine whether the Boston Scientific nitinol drug-eluting stent shows acceptable performance at 9 months when treating Superficial Femoral (SFA) and/or Proximal Popliteal Artery (PPA...

Companies [456 Associated Companies listed on BioPortfolio]

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Acolyte Biomedica Ltd

Acolyte Biomedica Ltd provides rapid diagnostic systems for clinical microbiology. Acolyte's BacLite® platform allows microbial detection in hours instead of days, improving laboratory workflow, redu...

BioMedica Diagnostics Inc.

BioMedica Diagnostics Inc. is a Canadian Medical Devices Company with a dedicated focus on providing Affordable Medical Diagnostic Solutions.The primary targets for our products are the emerging econo...

BIOMEDICA GRUPPE

BIOMEDICA GRUPPE Is a privately owned group of Central European companies, founded in 1978, with head-quarters in Vienna (Austria). Starting as a single distributing company, only it grew to a group o...

More Information about "Boston Biomedica Incorporated" on BioPortfolio

We have published hundreds of Boston Biomedica Incorporated news stories on BioPortfolio along with dozens of Boston Biomedica Incorporated Clinical Trials and PubMed Articles about Boston Biomedica Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Boston Biomedica Incorporated Companies in our database. You can also find out about relevant Boston Biomedica Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...


Corporate Database Quicklinks



Searches Linking to this Company Record